BIOMAT Database Logo BIOMAT Database Logo

1-acetyl-2-picolinoylhydrazine (NSC-68626) in the treatment of advanced cancer. 1969

K B Olson, and J Horton, and K L Pratt, and W J Paladine, and T Cunningham, and J Sullivan, and H Hosley, and D H Treble

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D010847 Picolines A group of compounds that are monomethyl derivatives of pyridines. (From Dorland, 28th ed) Picoline
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006834 Hydrazines Substituted derivatives of hydrazine (formula H2N-NH2). Hydrazide
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

K B Olson, and J Horton, and K L Pratt, and W J Paladine, and T Cunningham, and J Sullivan, and H Hosley, and D H Treble
Treatment of carcinoma of the lung with 1-acetyl-2-picolinoylhydrazine (NSC-68626).
August 1970, Cancer chemotherapy reports,
K B Olson, and J Horton, and K L Pratt, and W J Paladine, and T Cunningham, and J Sullivan, and H Hosley, and D H Treble
Clinical trials with 1-acetyl-2-picolinoylhydrazine (NSC-68626) in children.
January 1975, Cancer chemotherapy reports,
K B Olson, and J Horton, and K L Pratt, and W J Paladine, and T Cunningham, and J Sullivan, and H Hosley, and D H Treble
Hexamethylmelamine (NSC-13875) in the treatment of advanced cancer.
August 1972, Cancer chemotherapy reports,
K B Olson, and J Horton, and K L Pratt, and W J Paladine, and T Cunningham, and J Sullivan, and H Hosley, and D H Treble
Clinical pharmacologic study of 1-acetyl-2-picolinoyl hydrazine (NSC-68626).
April 1969, Cancer chemotherapy reports,
K B Olson, and J Horton, and K L Pratt, and W J Paladine, and T Cunningham, and J Sullivan, and H Hosley, and D H Treble
Treatment of advanced neoplastic disease with 1-(2-chlorethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037).
April 1973, Cancer chemotherapy reports,
K B Olson, and J Horton, and K L Pratt, and W J Paladine, and T Cunningham, and J Sullivan, and H Hosley, and D H Treble
Treatment of advanced gastrointestinal cancer with ememtine (NSC-33669).
January 1974, Cancer chemotherapy reports,
K B Olson, and J Horton, and K L Pratt, and W J Paladine, and T Cunningham, and J Sullivan, and H Hosley, and D H Treble
A phase 2 evaluation of 1-(2-chloroethyl)-3-(4- methylcyclohexyl)-1-nitrosourea (NSC 95441) in patients with advanced breast cancer.
January 1974, Cancer research,
K B Olson, and J Horton, and K L Pratt, and W J Paladine, and T Cunningham, and J Sullivan, and H Hosley, and D H Treble
DIETHYLSTILBESTROL (NSC-3070) AND TESTOSTERONE PROPIONATE (NSC-9166) THERAPY IN ADVANCED BREAST CANCER. 1. A COMPARISON.
September 1964, Cancer chemotherapy reports,
K B Olson, and J Horton, and K L Pratt, and W J Paladine, and T Cunningham, and J Sullivan, and H Hosley, and D H Treble
1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given concomitantly with cytosine arabinoside (NSC-63878) in the treatment of cancer.
October 1970, Cancer chemotherapy reports,
K B Olson, and J Horton, and K L Pratt, and W J Paladine, and T Cunningham, and J Sullivan, and H Hosley, and D H Treble
5-FLUOROURACIL (NSC-19893) TREATMENT OF ADVANCED CANCER IN AMBULATORY PATIENTS.
December 1963, Cancer chemotherapy reports,
Copied contents to your clipboard!